Injuries suffered in the somatosensory nervous system is what triggers neuropathic pain, which has several treatments available now. The global neuropathic pain market is expected to fetch USD 8017.43 million during the forecast period of 2018-2023. This report, by Market Research Future (MRFR) predicts a rise by 6.06%CAGR during the forecast period.
The global neuropathic pain market is expecting substantial rise due to the increasing participation from several companies who have realized the growth potential of the market : Astellas Pharma Inc. (Tokyo), Eli Lilly and Company (U.S.), Baxter Healthcare Corporation (U.S.), Biogen Inc. (U.S.), Sanofi S.A. (France), Pfizer, Inc. (U.S.), AstraZeneca (U.K.), Abbott Laboratories (U.S.), GlaxoSmithKline plc (U.K.), Johnson & Johnson Services Inc. (U.S.), and Depomed Inc. (U.S.). MRFR’s profiling of these companies include highlighting of their merger, acquisition, collaboration, product development, and others.
Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/1390
Several reasons have been playing supportive hands to ensure that the neuropathic pain market enjoys smooth ride ahead. The inclusion of several generic drugs to mitigate pain and their easy access can spur the market growth. On the other hand, growth in pain management clinic are expected to take the global market far ahead. Inflating healthcare expenditure is also expected to increase the number of takers. However, lack of situational awareness could prohibit the global market growth.
In July 2019, researchers at the New York University discovered a mathematical model to predict the neuropathic pain in both healthy people and patients.
Type, Indication, diagnosis method, treatment, end-users, and distribution channels are six major segments that have been included in the neuropathic pain market report for a thorough analysis by MRFR.
Based on the type, the Neuropathic Pain Market includes post traumatic neuropathy, peripheral neuropathy, phantom limb pain, post herpetic neuralgia (PHN), entrapment neuropathy, and trigeminal neuralgia.
Based on the indication, the neuropathic pain market comprises diabetic neuropathy, spinal stenosis, and chemotherapy-induced peripheral neuropathy.
Based on the diagnosis, the neuropathic pain market consists blood tests, imaging, and physical examination.
Based on the treatment, the neuropathic pain market is segmented into multimodal therapy and medication type. The medication type includes nerve blocks type, NSAIDs type, and antidepressant drugs type.
Based on the distribution channels, the neuropathic pain market comprises retail pharmacies & drug stores and online pharmacies.
Based on the end-users, the neuropathic pain market can be segmented into hospitals, clinics, and research organizations.
Region-specific study of the neuropathic pain market, as discussed by MRFR, covers the latest trends and opportunities across the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The report has an in-depth study of various countries with several factors and data to substantiate claims made.
The Americas had 37.03% share of the global market in 2017. The market dynamics are expected to remain the same as several factors like aged population and high technological integration in the field are expected to provide substantial traction for the revenue. Regional market has well-defined healthcare infrastructure and presence of various players, along with prosperous countries like the U.S., and Canada, are deemed to take the market across USD 2,226.8 million mark by 2023.
Europe earned revenues for almost 35.12% share of the global market in 2017. Backed up by initiatives taken by the World Health Organization (WHO) and Centers for Disease Control & Prevention (CDC) to create associated awareness helped the region revenue reach a valuation of USD 2,844.49 million by 2023.
The APAC neuropathic pain market had 24.26% of the global share in 2017. The huge patient pool in China, India, and Japan is expected to boost the market growth and help in attainment of 6.8% CAGR during the forecast period.
The MEA had only 3.59% of the global market which they clocked in 2017. The market is showing great inclination towards improving their healthcare standards and fetch in high dividends.
Get More Information on Neuropathic Pain Market Research Report Forecast to 2023 @ https://www.marketresearchfuture.com/reports/neuropathic-pain-market-1390
At Market Research Future (MRFR), our research analysts conduct a thorough objective analysis of the market while creating market reports by adhering to a rigorous set of standards which allow a truly comprehensive view of the market. Use of primary research strategies such as interviews can lead to accrual of highly relevant data. Secondary research entails a thorough analysis of past and present trends in a forward-looking manner.
In addition, market size estimation and validation use both top-down & bottom-up approaches to obtain data from the value and supply chain. The balanced number of buyers and suppliers will result in a negligible demand-supply gap. Credible resources are accessed and verified by analysts to understand the nuances of market factors with consistency. Competent data analysts use strong analytical tools to ascertain accurate analysis of very relevant parameters in an effort to provide clients with a conclusive and dependable view of the future.
List of Tables
Table 1 Market Synopsis
Table 2 List of Assumptions
Table 3 Global Neuropathic Pain Market, by Type 2015-2023 (Usd Million)
Table 4 Global Neuropathic Pain Market, for Peripheral Neuropathy by Region 2015-2023 (Usd Million)
Table 5 Global Neuropathic Pain Market, for Entrapment Neuropathy by Region 2015-2023 (Usd Million)
Table 6 Global Neuropathic Pain Market, for Phantom Limb Pain by Region 2015-2023 (Usd Million)
Table 7 Global Neuropathic Pain Market, for Trigeminal Neuralgia by Region 2015-2023 (Usd Million)
Table 8 Global Neuropathic Pain Market, for Post Herpetic Neuralgia (Phn) by Region 2015-2023 (Usd Million)
Table 9 Global Neuropathic Pain Market, for Post Traumatic Neuropathy by Region 2015-2023 (Usd Million)
Table 10 Global Neuropathic Pain Market, by Indication 2015-2023 (Usd Million)
List of Figures
Figure 1 Global Neuropathic Pain Market: Market Structure
Figure 2 Research Process of Mrfr
Figure 3 Top-down & Bottom-up Approach
Figure 4 Porter’s Five Forces Analysis: Global Neuropathic Pain Market
Figure 5 Value Chain: Global Neuropathic Pain Market
Figure 6 Global Neuropathic Pain Market, by Type, 2017 & 2023 (Usd Million)
Figure 7 Global Neuropathic Pain Market, by Indication, 2017 & 2023 (Usd Million)
Figure 8 Global Neuropathic Pain Market, by Diagnosis, 2017 & 2023 (Usd Million)
Figure 9 Global Neuropathic Pain Market, by Treatment, 2017 & 2023 (Usd Million)
Figure 10 Global Neuropathic Pain Market, by Distribution Channel, 2017 & 2023 (Usd Million)
Ask for your specific company profile and country level customization on reports.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Edibles.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar